메뉴 건너뛰기




Volumn 5, Issue 3 SUPPL., 2011, Pages

Management of familial hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ANTIFUNGAL AGENT; ATORVASTATIN; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; CYCLOSPORIN; CYTOCHROME P450; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FENOFIBRATE; FENOFIBRIC ACID; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROLIDE; NICOTINIC ACID; NICOTINIC ACID PLUS SIMVASTATIN; PITAVASTATIN; PROTEINASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN; STATIN;

EID: 79956277910     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.04.001     Document Type: Article
Times cited : (123)

References (84)
  • 1
    • 79952422178 scopus 로고    scopus 로고
    • Executive Summary: Heart Disease and Stroke Statistics 2011 Update: A Report from the American Heart Association. American Heart Association Heart Disease and Stroke Statistics Writing Group
    • American Heart Association
    • American Heart Association Executive Summary: Heart Disease and Stroke Statistics 2011 Update: A Report from the American Heart Association. American Heart Association Heart Disease and Stroke Statistics Writing Group Circulation 123 2011 459 463
    • (2011) Circulation , vol.123 , pp. 459-463
  • 2
    • 0037126526 scopus 로고    scopus 로고
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 5
    • 66349126280 scopus 로고    scopus 로고
    • PCSK9: A convertase that coordinates LDL catabolism
    • J.D. Horton, J.C. Cohen, and H.H. Hobbs PCSK9: A convertase that coordinates LDL catabolism J Lipid Res 50 2009 S172 S177
    • (2009) J Lipid Res , vol.50
    • Horton, J.D.1    Cohen, J.C.2    Hobbs, H.H.3
  • 6
    • 57349161570 scopus 로고    scopus 로고
    • Recognition and management of dyslipidemia in children and adolescents
    • DOI 10.1210/jc.2008-1270
    • P.O. Kwiterovich Jr. Recognition and management of dyslipidemia in children and adolescents J Clin Endocrinol Metab 93 2008 4200 4209 (Pubitemid 352789511)
    • (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.11 , pp. 4200-4209
    • Kwiterovich Jr., P.O.1
  • 7
    • 55749083573 scopus 로고    scopus 로고
    • Familial hypercholesterolaemia: Underdiagnosed and undertreated
    • A. Rees Familial hypercholesterolaemia: underdiagnosed and undertreated Eur Heart J 29 2008 2583 2584
    • (2008) Eur Heart J , vol.29 , pp. 2583-2584
    • Rees, A.1
  • 9
    • 51249096285 scopus 로고    scopus 로고
    • Familial hypercholesterolemia: Summary of NICE guidance
    • on behalf of the Guidance Development Group R.
    • A.S. Wierzbicki, S.E. Humphries, R. Minhas on behalf of the Guidance Development Group Familial hypercholesterolemia: summary of NICE guidance BMJ 337 2008 509 510
    • (2008) BMJ , vol.337 , pp. 509-510
    • Wierzbicki, A.S.1    Humphries, S.E.2    Minhas, R.3
  • 11
    • 77955779223 scopus 로고    scopus 로고
    • Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia
    • M. Harada-Shiba, T. Sugisawa, and H. Makino Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia J Atheroscler Thromb 17 2010 667 674
    • (2010) J Atheroscler Thromb , vol.17 , pp. 667-674
    • Harada-Shiba, M.1    Sugisawa, T.2    Makino, H.3
  • 14
    • 78751622912 scopus 로고    scopus 로고
    • Lowering LDL cholesterol through diet: Potential role in the statin era
    • E. Bruckert, and D. Rosenbaum Lowering LDL cholesterol through diet: potential role in the statin era Curr Opin Lipidol 22 2011 43 48
    • (2011) Curr Opin Lipidol , vol.22 , pp. 43-48
    • Bruckert, E.1    Rosenbaum, D.2
  • 16
    • 60249092628 scopus 로고    scopus 로고
    • Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake
    • I. Demonty, R.T. Ras, and H.C.M. van der Knaap Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake J Nutr 139 2009 271 284
    • (2009) J Nutr , vol.139 , pp. 271-284
    • Demonty, I.1    Ras, R.T.2    Van Der Knaap, H.C.M.3
  • 17
    • 0026781014 scopus 로고
    • Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis
    • A.M. Dattilo, and P.M. Kris-Etherton Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis Am J Clin Nutr 56 1992 320 328
    • (1992) Am J Clin Nutr , vol.56 , pp. 320-328
    • Dattilo, A.M.1    Kris-Etherton, P.M.2
  • 18
    • 78650288540 scopus 로고    scopus 로고
    • Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial
    • A.D. Gepner, M.E. Piper, H.M. Johnson, M.C. Fiore, T.B. Baker, and J.H. Stein Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial Am Heart J 161 2011 145 151
    • (2011) Am Heart J , vol.161 , pp. 145-151
    • Gepner, A.D.1    Piper, M.E.2    Johnson, H.M.3    Fiore, M.C.4    Baker, T.B.5    Stein, J.H.6
  • 19
    • 0024532390 scopus 로고
    • Dietary treatment of familial hypercholesterolemia
    • W.E. Connor, and S.L. Connor Dietary treatment of familial hypercholesterolemia Arteriosclerosis 9 1Supppl 1989 I91 105
    • (1989) Arteriosclerosis , vol.9 , Issue.1 SUPPL. , pp. 91-105
    • Connor, W.E.1    Connor, S.L.2
  • 20
    • 0034994041 scopus 로고    scopus 로고
    • Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia
    • M.H. Davidson, P. Toth, and S. Weiss Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia Clin Cardiol 24 2001 467 474 (Pubitemid 32520218)
    • (2001) Clinical Cardiology , vol.24 , Issue.6 , pp. 467-474
    • Davidson, M.H.1    Toth, P.2    Weiss, S.3    McKenney, J.4    Hunninghake, D.5    Isaacsohn, J.6    Donovan, J.M.7    Burke, S.K.8
  • 22
    • 31144479575 scopus 로고    scopus 로고
    • Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs
    • DOI 10.1016/j.amjcard.2005.08.056, PII S0002914905018266
    • A.C. Goldberg, R.E. Ostlund Jr., J.H. Bateman, L. Schimmoeller, T.B. McPherson, and C.A. Spilburg Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs Am J Cardiol 97 2006 376 379 (Pubitemid 43133053)
    • (2006) American Journal of Cardiology , vol.97 , Issue.3 , pp. 376-379
    • Goldberg, A.C.1    Ostlund Jr., R.E.2    Bateman, J.H.3    Schimmoeller, L.4    McPherson, T.B.5    Spilburg, C.A.6
  • 23
    • 0037541585 scopus 로고    scopus 로고
    • A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
    • DOI 10.1016/S0021-9150(02)00330-1, PII S0021915002003301
    • D. Marks, M. Thorogood, H.A. Neil, and S.E. Humphries A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia Atherosclerosis 168 2003 1 14 (Pubitemid 36559596)
    • (2003) Atherosclerosis , vol.168 , Issue.1 , pp. 1-14
    • Marks, D.1    Thorogood, M.2    Neil, H.A.W.3    Humphries, S.E.4
  • 24
    • 0027495529 scopus 로고
    • Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia
    • DOI 10.1016/0021-9150(93)90260-2
    • M.D. Feher, J.C. Webb, and D.D. Patel Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia Atherosclerosis 103 1993 171 180 (Pubitemid 23360931)
    • (1993) Atherosclerosis , vol.103 , Issue.2 , pp. 171-180
    • Feher, M.D.1    Webb, J.C.2    Patel, D.D.3    Lant, A.F.4    Mayne, P.D.5    Knight, B.L.6    Soutar, A.K.7
  • 25
    • 0036345274 scopus 로고    scopus 로고
    • Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia
    • A. Goldammer, S. Wiltschnig, and G. Heinz Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia Metabolism 51 2002 976 980
    • (2002) Metabolism , vol.51 , pp. 976-980
    • Goldammer, A.1    Wiltschnig, S.2    Heinz, G.3
  • 26
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastatin Survival Study
    • Scandinavian Simvastatin Survival Study Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 27
    • 0032032592 scopus 로고    scopus 로고
    • Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The CURVES study)
    • DOI 10.1016/S0002-9149(97)00965-X, PII S000291499700965X
    • P. Jones, S. Kafonek, I. Laurora, and D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol 81 1998 582 587 (Pubitemid 28182422)
    • (1998) American Journal of Cardiology , vol.81 , Issue.5 , pp. 582-587
    • Jones, P.1    Kafonek, S.2    Laurora, I.3    Hunninghake, D.4
  • 30
    • 33645888317 scopus 로고    scopus 로고
    • An assessment of statin safety by hepatologists
    • D.E. Cohen, F.A. Anania, and N. Chalasani An assessment of statin safety by hepatologists Am J Cardiol 97 2006 77C 81C
    • (2006) Am J Cardiol , vol.97
    • Cohen, D.E.1    Anania, F.A.2    Chalasani, N.3
  • 31
    • 33645847841 scopus 로고    scopus 로고
    • National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by muscle experts
    • P.D. Thompson, P.M. Clarkson, and R.S. Rosenson National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by muscle experts Am J Cardiol 97 2006 69C 76C
    • (2006) Am J Cardiol , vol.97
    • Thompson, P.D.1    Clarkson, P.M.2    Rosenson, R.S.3
  • 32
    • 33645889332 scopus 로고    scopus 로고
    • National Lipid Association Statin Safety Task Force Liver Expert Panel. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
    • J.M. McKenney, M.H. Davidson, T.A. Jacobson, and J.R. Guyton National Lipid Association Statin Safety Task Force Liver Expert Panel. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force Am J Cardiol 2006 89C 94C
    • (2006) Am J Cardiol
    • McKenney, J.M.1    Davidson, M.H.2    Jacobson, T.A.3    Guyton, J.R.4
  • 33
    • 31344467118 scopus 로고    scopus 로고
    • Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention
    • DOI 10.1016/j.ahj.2005.04.003, PII S0002870305003613
    • Z. Zhou, E. Rahme, and L. Pilote Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention Am Heart J 151 2006 273 281 (Pubitemid 43144726)
    • (2006) American Heart Journal , vol.151 , Issue.2 , pp. 273-281
    • Zhou, Z.1    Rahme, E.2    Pilote, L.3
  • 35
    • 0037188567 scopus 로고    scopus 로고
    • Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
    • DOI 10.1161/01.CIR.0000018744.58460.62
    • C. Gagne, D. Gauder, and E. Bruckert Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia Circulation 105 2002 2469 2475 (Pubitemid 34568966)
    • (2002) Circulation , vol.105 , Issue.21 , pp. 2469-2475
    • Gagne, C.1    Gaudet, D.2    Bruckert, E.3
  • 36
    • 25844513563 scopus 로고    scopus 로고
    • Colesevelam HCl and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia
    • DOI 10.1097/01.mjt.0000155109.69831.a3
    • M.J. Zema Colesevelam HCL and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia Am J Ther 12 2005 306 310 (Pubitemid 41391808)
    • (2005) American Journal of Therapeutics , vol.12 , Issue.4 , pp. 306-310
    • Zema, M.J.1
  • 38
    • 79956268616 scopus 로고    scopus 로고
    • Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
    • I. Hamilton-Craig, K. Kostner, D. Colquhoun, and S. Woodhouse Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia Vasc Health Risk Manag 6 2010 1023 1037
    • (2010) Vasc Health Risk Manag , vol.6 , pp. 1023-1037
    • Hamilton-Craig, I.1    Kostner, K.2    Colquhoun, D.3    Woodhouse, S.4
  • 40
    • 0021350001 scopus 로고
    • The Lipid Research Clinics coronary primary prevention trial results, I: Reduction in the incidence of coronary heart disease
    • Lipid Research Clinics Program
    • Lipid Research Clinics Program The Lipid Research Clinics coronary primary prevention trial results, I: reduction in the incidence of coronary heart disease JAMA 251 1984 351 364
    • (1984) JAMA , vol.251 , pp. 351-364
  • 41
    • 77952525229 scopus 로고    scopus 로고
    • Trip Study Group. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week multicenter, randomized, double-blind controlled trial
    • R. Huijgen, E.J. Abbink, and E. Bruckert Trip Study Group. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind controlled trial Clin Ther 32 2010 615 625
    • (2010) Clin Ther , vol.32 , pp. 615-625
    • Huijgen, R.1    Abbink, E.J.2    Bruckert, E.3
  • 42
    • 0025933491 scopus 로고
    • Nicotinic acid for the treatment of hyperlipoproteinemia
    • J.M. Drood, P.J. Zimetbaum, and W.H. Frishman Nicotinic acid for the treatment of hyperlipoproteinemia J Clin Pharmacol 31 1991 641 650
    • (1991) J Clin Pharmacol , vol.31 , pp. 641-650
    • Drood, J.M.1    Zimetbaum, P.J.2    Frishman, W.H.3
  • 43
    • 0032542277 scopus 로고    scopus 로고
    • Clinical trial experience with extendedrelease niacin (niaspan): Dose- escalation study
    • DOI 10.1016/S0002-9149(98)00952-7, PII S002914998009527
    • A.C. Goldberg Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study Am J Cardiol 82 1998 35U 38U (Pubitemid 29047614)
    • (1998) American Journal of Cardiology , vol.82 , Issue.12 A
    • Goldberg, A.C.1
  • 44
    • 0032542367 scopus 로고    scopus 로고
    • A new extended-release niacin (niaspan): Efficacy, tolerability, and safety in hypercholesterolemic patients
    • DOI 10.1016/S0002-9149(98)00732-2, PII S000914998007322
    • J.M. Morgan, D.M. Capuzzi, and J.R. Guyton A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients Am J Cardiol 82 1998 29U 34U (Pubitemid 29047613)
    • (1998) American Journal of Cardiology , vol.82 , Issue.12 A
    • Morgan, J.M.1    Capuzzi, D.M.2    Guyton, J.R.3
  • 45
    • 0032542274 scopus 로고    scopus 로고
    • Treatment of hyperlipidemia with combined niacin-statin regimens
    • DOI 10.1016/S0002-9149(98)00955-2, PII S002914998009552
    • J.R. Guyton, and D.M. Capuzzi Treatment of hyperlipidemia with combined niacin-statin regimens Am J Cardiol 82 1998 82U 84U (Pubitemid 29047618)
    • (1998) American Journal of Cardiology , vol.82 , Issue.12 A
    • Guyton, J.R.1    Capuzzi, D.M.2
  • 47
    • 70349334010 scopus 로고    scopus 로고
    • Myopathy with statin-fibrate combination therapy: Clinical considerations
    • T.A. Jacobson Myopathy with statin-fibrate combination therapy: clinical considerations Nat Rev Endocrinol 5 2009 507 518
    • (2009) Nat Rev Endocrinol , vol.5 , pp. 507-518
    • Jacobson, T.A.1
  • 48
    • 0014207423 scopus 로고
    • Homozygous cutaneo-tendinous forms of hypercholesterolemic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment
    • J.L. de Gennes, R. Touraine, B. Maunand, J. Truffert, and P. Laudat Homozygous cutaneo-tendinous forms of hypercholesterolemic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment Bull Mem Soc Med Hop Paris 118 1967 1377 1402
    • (1967) Bull Mem Soc Med Hop Paris , vol.118 , pp. 1377-1402
    • De Gennes, J.L.1    Touraine, R.2    Maunand, B.3    Truffert, J.4    Laudat, P.5
  • 49
    • 0036796663 scopus 로고    scopus 로고
    • First steps toward the establishment of a German low-density lipoprotein-apheresis registry: Recommendations for the indication and for quality management
    • DOI 10.1046/j.1526-0968.2002.00426.x
    • V. Schettler, E. Wieland, V.W. Armstrong, T. Kleinoeder, R.W. Grunewald, and G.A. Muller Participants of the Gottingen Consensus Conferences. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management Ther Apher 6 2002 381 383 (Pubitemid 35203285)
    • (2002) Therapeutic Apheresis , vol.6 , Issue.5 , pp. 381-383
    • Schettler, V.1    Wieland, E.2    Armstrong, V.W.3    Kleinoeder, T.4    Grunewald, R.W.5    Muller, G.A.6
  • 50
    • 0037371166 scopus 로고    scopus 로고
    • LDL apheresis
    • DOI 10.1016/S0021-9150(02)00251-4, PII S0021915002002514
    • G.R. Thompson LDL apheresis Atherosclerosis 167 2003 1 13 (Pubitemid 36258395)
    • (2003) Atherosclerosis , vol.167 , Issue.1 , pp. 1-13
    • Thompson, G.R.1
  • 52
    • 0033811877 scopus 로고    scopus 로고
    • The rebound of lipoproteins after LDL apheresis. Kinetics and estimation of mean lipoprotein levels
    • A.A. Kroon, M.A. van't Hof, P.N. Demacker, and A.F. Stalenhoef The rebound of lipoproteins after LDL apheresis. Kinetics and estimation of mean lipoprotein levels Atherosclerosis 152 2000 519 526
    • (2000) Atherosclerosis , vol.152 , pp. 519-526
    • Kroon, A.A.1    Van'T Hof, M.A.2    Demacker, P.N.3    Stalenhoef, A.F.4
  • 53
    • 0030716524 scopus 로고    scopus 로고
    • Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
    • A.D. Marais, R.P. Naoumova, J.C. Firth, C. Penny, C.K. Neuwirth, and G.R. Thompson Decreased production of low-density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia J Lipid Res 38 1997 2071 2078 (Pubitemid 27468015)
    • (1997) Journal of Lipid Research , vol.38 , Issue.10 , pp. 2071-2078
    • Marais, A.D.1    Naoumova, R.P.2    Firth, J.C.3    Penny, C.4    Neuwirth, C.K.Y.5    Thompson, G.R.6
  • 54
    • 0028061644 scopus 로고
    • Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy
    • M. Pfohl, R.P. Naoumova, and C. Klass Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG CoA reductase inhibitor therapy J Lipid Res 35 1994 1946 1955 (Pubitemid 24353067)
    • (1994) Journal of Lipid Research , vol.35 , Issue.11 , pp. 1946-1955
    • Pfohl, M.1    Naoumova, R.P.2    Klass, C.3    Knisel, W.4    Jakober, B.5    Risler, T.6    Thompson, G.R.7
  • 56
    • 0026689871 scopus 로고
    • Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study. The LARS Investigators
    • R. Tatami, N. Inove, and H. Itoh Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators Atherosclerosis 95 1992 1 13
    • (1992) Atherosclerosis , vol.95 , pp. 1-13
    • Tatami, R.1    Inove, N.2    Itoh, H.3
  • 57
    • 0028029899 scopus 로고
    • The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia: Results of a multicenter LDL apheresis study
    • T. Waidner, D. Franzen, and W. Voelker The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study Clin Investig 72 1994 858 863 (Pubitemid 24342968)
    • (1994) Clinical Investigator , vol.72 , Issue.11 , pp. 858-863
    • Waidner, T.1    Franzen, D.2    Voelker, W.3    Ritter, M.4    Borberg, H.5    Hombach, V.6    Hopp, H.W.7
  • 59
    • 0029103672 scopus 로고
    • Familial Hypercholesterolemia Regression Study: A randomised trial of low-density-lipoprotein apheresis
    • G.R. Thompson, V.M. Maher, and S. Matthews Familial Hypercholesterolemia Regression Study: a randomised trial of low-density-lipoprotein apheresis Lancet 345 1995 811 816
    • (1995) Lancet , vol.345 , pp. 811-816
    • Thompson, G.R.1    Maher, V.M.2    Matthews, S.3
  • 61
    • 0032535310 scopus 로고    scopus 로고
    • Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
    • DOI 10.1016/S0002-9149(98)00692-4, PII S0002914998006924
    • H. Mabuchi, J. Koizumi, and M. Shimizu Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group Am J Cardiol 82 1998 1489 1495 (Pubitemid 29006472)
    • (1998) American Journal of Cardiology , vol.82 , Issue.12 , pp. 1489-1495
    • Mabuchi, H.1    Koizumi, J.2    Shimizu, M.3    Kajinami, K.4    Miyamoto, S.5    Ueda, K.6    Takegoshi, T.7
  • 62
    • 0031863995 scopus 로고    scopus 로고
    • Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia
    • DOI 10.1016/S0026-0495(98)90127-5
    • W.O. Ritcher, M.G. Donner, B. Hofling, and P. Schwandt Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia Metabolism 47 1998 863 868 (Pubitemid 28313196)
    • (1998) Metabolism: Clinical and Experimental , vol.47 , Issue.7 , pp. 863-868
    • Richter, W.O.1    Donner, M.G.2    Hofling, B.3    Schwandt, P.4
  • 63
    • 0031014389 scopus 로고    scopus 로고
    • Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans
    • O. Tamai, H. Matsuoka, H. Itabe, Y. Wada, K. Kohno, and T. Imaizumi Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans Circulation 95 1997 76 82 (Pubitemid 27029946)
    • (1997) Circulation , vol.95 , Issue.1 , pp. 76-82
    • Tamai, O.1    Matsuoka, H.2    Itabe, H.3    Wada, Y.4    Kohno, K.5    Imaizumi, T.6
  • 64
    • 1942522060 scopus 로고    scopus 로고
    • Improvement of Endothelium-Dependent Coronary Vasodilation after a Single LDL Apheresis in Patients with Hypercholesterolemia
    • DOI 10.1002/jca.20000
    • K. Igarashi, M. Tsuji, M. Nishimura, and M. Horimoto Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia J Clin Apher 19 2004 11 16 (Pubitemid 38509397)
    • (2004) Journal of Clinical Apheresis , vol.19 , Issue.1 , pp. 11-16
    • Igarashi, K.1    Tsuji, M.2    Nishimura, M.3    Horimoto, M.4
  • 65
    • 0042316781 scopus 로고    scopus 로고
    • Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis
    • DOI 10.1046/j.1526-0968.2003.00078.x
    • M. Sato, and I. Amano Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis Ther Apher Dial 7 2003 419 424 (Pubitemid 37082030)
    • (2003) Therapeutic Apheresis , vol.7 , Issue.4 , pp. 419-424
    • Sato, M.1    Amano, I.2
  • 67
    • 33847005410 scopus 로고    scopus 로고
    • Apheresis in coronary heart disease with elevated Lp(a): A review of Lp(a) as a risk factor and its management
    • C. Keller Apheresis in coronary heart disease with elevated Lp(a): a review of Lp(a) as a risk factor and its management Ther Apher Dial 11 2007 2 8
    • (2007) Ther Apher Dial , vol.11 , pp. 2-8
    • Keller, C.1
  • 68
    • 19544371727 scopus 로고    scopus 로고
    • Is lipoprotein(a)-apheresis useful?
    • R. Bambauer Is lipoprotein(a)-apheresis useful? Ther Apher Dial 9 2005 142 147
    • (2005) Ther Apher Dial , vol.9 , pp. 142-147
    • Bambauer, R.1
  • 69
    • 33748987891 scopus 로고    scopus 로고
    • A systematic review of LDL apheresis in the treatment of cardiovascular disease
    • DOI 10.1016/j.atherosclerosis.2006.02.030, PII S0021915006000773
    • J. Thompsen, and P.D. Thompson A systematic review of LDL apheresis in the treatment of cardiovascular disease Atherosclerosis 189 2006 31 38 (Pubitemid 44444914)
    • (2006) Atherosclerosis , vol.189 , Issue.1 , pp. 31-38
    • Thompsen, J.1    Thompson, P.D.2
  • 70
    • 79956258126 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration (FDA) Accessed February 8, 2011
    • U.S. Food and Drug Administration (FDA). PMA final decisions rendered for September 1997. H.E.L.P. Accessed February 8, 2011. Available at http://www.accessdata.fda.gov/cdrh-docs/pdf/p940016.pdf
    • PMA Final Decisions Rendered for September 1997. H.E.L.P
  • 73
    • 33750978670 scopus 로고    scopus 로고
    • Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
    • DOI 10.1016/j.atherosclerosis.2006.01.002, PII S0021915006000281
    • A.L. Amundsen, J. Khoury, P.O. Iversen, C. Bergei, L. Ose, and S. Tonstad Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia Atherosclerosis 189 2006 451 457 (Pubitemid 44740297)
    • (2006) Atherosclerosis , vol.189 , Issue.2 , pp. 451-457
    • Amundsen, A.L.1    Khoury, J.2    Iversen, P.O.3    Bergei, C.4    Ose, L.5    Tonstad, S.6    Retterstol, K.7
  • 74
    • 0038487270 scopus 로고    scopus 로고
    • Differential indication of lipoprotein apheresis during pregnancy
    • DOI 10.1046/j.1526-0968.2003.00066.x
    • R. Klingel, B. Gohlen, A. Schwarting, F. Himmelsbach, and R. Straube Differential indication of lipoprotein apheresis during pregnancy Ther Apher Dial 7 2003 359 364 (Pubitemid 36859527)
    • (2003) Therapeutic Apheresis , vol.7 , Issue.3 , pp. 359-364
    • Klingel, R.1    Gohlen, B.2    Schwarting, A.3    Himmelsbach, F.4    Straube, R.5
  • 75
    • 0035845991 scopus 로고    scopus 로고
    • United States cholesterol guidelines 2001: Expanded scope of intensive low-density lipoprotein-lowering therapy
    • PII S0002914901019312
    • S.M. Grundy United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy Am J Cardiol 88 2001 23J 27J (Pubitemid 32938248)
    • (2001) American Journal of Cardiology , vol.88 , Issue.7 SUPPL. 2
    • Grundy, S.M.1
  • 76
    • 23744444361 scopus 로고    scopus 로고
    • Recent National Cholesterol Education Program Adult Treatment Panel III update: Adjustments and options
    • DOI 10.1016/j.amjcard.2005.06.006, PII S0002914905009227
    • N.J. Stone, S. Bilek, and S. Rosenbaum Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options Am J Cardiol 96 2005 53E 59E (Pubitemid 41140371)
    • (2005) American Journal of Cardiology , vol.96 , Issue.4 SUPPL.
    • Stone, N.J.1    Bilek, S.2    Rosenbaum, S.3
  • 77
    • 59649121269 scopus 로고    scopus 로고
    • Other therapies for reducing low-density lipoprotein cholesterol: Medications in development
    • E.A. Stein Other therapies for reducing low-density lipoprotein cholesterol: medications in development Endocrinol Metab Clin North Am 38 2009 99 119
    • (2009) Endocrinol Metab Clin North Am , vol.38 , pp. 99-119
    • Stein, E.A.1
  • 78
    • 0037167692 scopus 로고    scopus 로고
    • Vaccination against atherosclerosis: Science or fiction?
    • G.K. Hansson Vaccination against atherosclerosis: science or fiction? Circulation 106 2002 1599 1601
    • (2002) Circulation , vol.106 , pp. 1599-1601
    • Hansson, G.K.1
  • 79
    • 34748859659 scopus 로고    scopus 로고
    • ISIS 301012 gene therapy for hypercholesterolemia: Sense, antisense, or nonsense?
    • DOI 10.1345/aph.1K065
    • M.K. Ito ISIS 301012 Gene Therapy for Hypercholesterolemia: Sense, Antisense, or Nonsense? Ann Pharmacother 41 2007 1669 1678 (Pubitemid 47479796)
    • (2007) Annals of Pharmacotherapy , vol.41 , Issue.10 , pp. 1669-1678
    • Ito, M.K.1
  • 80
    • 34250772826 scopus 로고    scopus 로고
    • Current status of cardiovascular gene therapy
    • DOI 10.1038/sj.mt.6300175, PII 6300175
    • T.T. Rissanen, and S. Yla-Herttuala Current status of cardiovascular gene therapy Molec Ther 15 2007 1233 1247 (Pubitemid 46965318)
    • (2007) Molecular Therapy , vol.15 , Issue.7 , pp. 1233-1247
    • Rissanen, T.T.1    Yla-Herttuala, S.2
  • 81
    • 77957867597 scopus 로고    scopus 로고
    • NLA Symposium on Familial Hypercholesterolemia. Novel therapies and new targets of treatment familial hypercholesterolemia
    • A.C. Goldberg NLA Symposium on Familial Hypercholesterolemia. Novel therapies and new targets of treatment familial hypercholesterolemia J Clin Lipidol 4 2010 350 356
    • (2010) J Clin Lipidol , vol.4 , pp. 350-356
    • Goldberg, A.C.1
  • 82
    • 0035066709 scopus 로고    scopus 로고
    • Evaluation of the antihyperlipidemic properties of dietary supplements
    • M.F. Caron, and C.M. White Evaluation of the antihyperlipidemic properties of dietary supplements Pharmacotherapy 21 2001 481 487 (Pubitemid 32275276)
    • (2001) Pharmacotherapy , vol.21 , Issue.4 , pp. 481-487
    • Caron, M.F.1    White, C.M.2
  • 83
    • 77954371866 scopus 로고    scopus 로고
    • Nutraceuticals and atherosclerosis: Human trials
    • L. Badimon, G. Vilahur, and T. Padro Nutraceuticals and atherosclerosis: human trials Cardiovasc Ther 28 2010 202 215
    • (2010) Cardiovasc Ther , vol.28 , pp. 202-215
    • Badimon, L.1    Vilahur, G.2    Padro, T.3
  • 84
    • 70449501709 scopus 로고    scopus 로고
    • Nutritional supplements and serum lipids: Does anything work?
    • M.P. McGowan, and S. Proulx Nutritional supplements and serum lipids: does anything work? Curr Atheroscler Rep 11 2009 470 476
    • (2009) Curr Atheroscler Rep , vol.11 , pp. 470-476
    • McGowan, M.P.1    Proulx, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.